DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Symbiotec Pharmalab Limited (SYMBIOTEC) share price today?

Symbiotec Pharmalab Limited (SYMBIOTEC) is trading at ₹1,276.4 on the NSE, up 1.71% on the day. Source: DocStoX.

What is the PE ratio of Symbiotec Pharmalab Limited?

Symbiotec Pharmalab Limited has a price-to-earnings (PE) ratio of 72.9 in the Healthcare sector.

What is the market capitalisation of Symbiotec Pharmalab Limited?

Symbiotec Pharmalab Limited has a market capitalisation of approximately ₹8,215 crore.

Is Symbiotec Pharmalab Limited a profitable company?

Symbiotec Pharmalab Limited generates a return on equity of 11.7% with a net profit margin of 12.7%. That is a modest return on shareholder capital.

What is the 52-week high and low of SYMBIOTEC?

Symbiotec Pharmalab Limited (SYMBIOTEC) has traded between ₹934.2 and ₹1,309.9 over the past 52 weeks, against a current price of ₹1,276.4.

Symbiotec Pharmalab Limited

₹1,276.40▲ +21.50 (+1.71%)

SYMBIOTEC·NSE·Healthcare

Market Cap

8215.14 Cr

PE Ratio

72.90

Volume

8,80,197

Day High - Low

1309.90 - 1235.00

52W High-Low

1309.90 - 934.20

₹1,276.40▲ +21.50 (+1.71%)

Market Cap8215.14 Cr

PE Ratio72.90

Volume8,80,197

Day High - Low1309.90 - 1235.00

52W High-Low1309.90 - 934.20

Symbiotec Pharmalab Limited (SYMBIOTEC): company summary

Symbiotec Pharmalab Limited (SYMBIOTEC) is a small-cap Healthcare company valued at ₹8,215 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move: Symbiotec Pharmalab Limited last traded at ₹1,276.4, modestly up 1.71% on the day.
Financial performance: Revenue has been growing strongly at 15.3% a year over three years; profit grew 68.5% a year, ahead of revenue — margins are expanding. Return on equity is 11.7%.
Valuation multiples: The stock trades at 72.9 times earnings, a premium to the Healthcare median of 32.0, 5.62 times book value.

Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

4.2/10

Weak

Fair Value

ROE

11.70%

Average

P/E

72.90x

Expensive

Debt / Equity

0.34

Moderate

Industry

Healthcare

Pharmaceuticals

Overall View

Mixed

Price performance

Day₹1235

₹1310

52W₹934.20

₹1310

DocStoX take

Supported by momentum (7.5) and quality (7.0), but held back by valuation (0.0). Momentum looks strong at 7.5, but that is offset by valuation at 0.0 and growth at 1.7. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence

4.2

/10

Weak

Quality

Solid

ROE 11.7%

Valuation

Expensive

P/E 72.9×

Growth

Flat

Revenue +6.5% 5Y CAGR

Risk

Moderate

D/E 0.34

Momentum

Strong

91% of 52-week range

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹1,276

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹8,215 Cr

52W High / Low

₹1310 / ₹934

Dividend Yield

0.00%

Promoter Holding

33.28%

EPS (TTM)

₹17.51

Book Value

₹202.32

Key highlights

Profitable in all of the last 5 years
Profit shrinking 2% a year
39% of promoter holding is pledged

1 Positive4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Explore Symbiotec Pharmalab Limited’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Symbiotec Pharmalab Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Laurus Labs Limited Cipla Limited Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited Mankind Pharma Limited Lupin Limited Manipal Health Enterprises Limited

Compare Symbiotec Pharmalab Limited with peers

Symbiotec Pharmalab Limited vs Sun Pharmaceutical Industries Limited Symbiotec Pharmalab Limited vs Divi's Laboratories Limited Symbiotec Pharmalab Limited vs Torrent Pharmaceuticals Limited Symbiotec Pharmalab Limited vs Apollo Hospitals Enterprise Limited Symbiotec Pharmalab Limited vs Zydus Lifesciences Limited Symbiotec Pharmalab Limited vs Laurus Labs Limited

Related tools & concepts

Value Symbiotec Pharmalab Limited with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

SYMBIOTEC newsLatest coverage & filings Open screenerFilter the whole market